{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:27:26Z","timestamp":1793600846609,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jad.2026.121662","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T17:07:25Z","timestamp":1774285645000},"page":"121662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis"],"prefix":"10.1016","volume":"406","author":[{"given":"Guy M.","family":"Goodwin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott T.","family":"Aaronson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Carhart-Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Croal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Feifel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Hellerstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad I.","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namik","family":"Kirlic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasmus W.","family":"Licht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Marwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ania","family":"Nowakowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1\u0161","family":"P\u00e1len\u00ed\u010dek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Repantis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Schoevers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hollie","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jair C.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metten","family":"Somers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mourad","family":"Wahba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan H.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew B.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidney","family":"Zisook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Malievskaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2026.121662_bb0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5","year":"2013"},{"key":"10.1016\/j.jad.2026.121662_bb0010","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1017\/S0033291724002204","article-title":"Validation of the imperial psychedelic predictor scale","volume":"54","author":"Angyus","year":"2024","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2026.121662_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpr.2020.101921","article-title":"Therapeutic alliance as a mediator of change: a systematic review and evaluation of research","volume":"82","author":"Baier","year":"2020","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.jad.2026.121662_bb0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1176\/appi.ajp.20230643","article-title":"Pharmacological and nonpharmacological components of psychedelic treatments: the whole is not the sum of the parts","volume":"181","author":"Bogenschutz","year":"2024","journal-title":"AJP"},{"key":"10.1016\/j.jad.2026.121662_bb0025","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2026.121662_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1439347","article-title":"The association between diverse psychological protocols and the efficacy of psilocybin-assisted therapy for clinical depressive symptoms: a Bayesian meta-analysis","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jad.2026.121662_bb0035","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2026.121662_bb0040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1176\/appi.ajp.20230667","article-title":"\u201cPsychedelic assisted therapy\u201d must not be retired","volume":"181","author":"Deckel","year":"2024","journal-title":"AJP"},{"key":"10.1016\/j.jad.2026.121662_bb0045","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-2007-979351","article-title":"The standardized psychometric assessment of altered states of consciousness (ASCs) in humans","volume":"31","author":"Dittrich","year":"1998","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jad.2026.121662_bb0050","series-title":"Silence is Golden: Documenting the Speech Production of Patients and Therapists in Psilocybin Treatment of Post-traumatic Stress Disorder","author":"Dougherty","year":"2025"},{"key":"10.1016\/j.jad.2026.121662_bb0055","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1176\/appi.ajp.20230572","article-title":"Psilocybin without psychotherapy: a cart without a horse?","volume":"181","author":"Earleywine","year":"2024","journal-title":"AJP"},{"key":"10.1016\/j.jad.2026.121662_bb0060","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.54843","article-title":"Psychological therapy quantity and depressive symptom reduction in psychedelic-assisted therapy: a systematic review and meta-analysis","volume":"9","author":"Florineth","year":"2026","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jad.2026.121662_bb0065","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000546270","article-title":"In psychedelic-assisted therapy, the alliance in the psychotherapy component is as important as the drug","volume":"94","author":"Fl\u00fcckiger","year":"2025","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jad.2026.121662_bb0070","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2026.121662_bb0075","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jad.2023.01.108","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression: impact on patient-reported depression severity, anxiety, function, and quality of life","volume":"327","author":"Goodwin","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.121662_bb0080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1176\/appi.ajp.20221043","article-title":"Must psilocybin always \u201cassist psychotherapy\u201d?","volume":"181","author":"Goodwin","year":"2023","journal-title":"AJP"},{"issue":"1","key":"10.1016\/j.jad.2026.121662_bb0085","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1176\/appi.ajp.20230905","article-title":"Psychological support for psilocybin treatment: reply to letters on our commentary","volume":"181","author":"Goodwin","year":"2024","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.121662_bb0090","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jad.2024.12.061","article-title":"The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression","volume":"372","author":"Goodwin","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.121662_bb0095","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.121662_bb0100","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S2215-0366(23)00363-2","article-title":"Treatment with psychedelics is psychotherapy: beyond reductionism","volume":"11","author":"Gr\u00fcnder","year":"2024","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2026.121662_bb0105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2026.121662_bb0110","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.genhosppsych.2025.07.020","article-title":"A dose of therapy with psilocybin - a meta-analysis of the relationship between the amount of therapy hours and treatment outcomes in psychedelic-assisted therapy","volume":"96","author":"Hultgren","year":"2025","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.jad.2026.121662_bb0115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1348\/147608309X472081","article-title":"Therapeutic alliance and outcome in routine psychiatric out-patient treatment: patient factors and outcome","volume":"83","author":"Johansson","year":"2010","journal-title":"Psychol. Psychother. Theory Res. Pract."},{"key":"10.1016\/j.jad.2026.121662_bb0120","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1176\/appi.ajp.20230884","article-title":"Compass psychological support model for COMP360 psilocybin treatment of serious mental health conditions","volume":"182","author":"Kirli\u0107","year":"2025","journal-title":"AJP"},{"key":"10.1016\/j.jad.2026.121662_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0300501","article-title":"The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder","volume":"19","author":"Levin","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2026.121662_bb0130","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/s41386-019-0324-9","article-title":"Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels","volume":"44","author":"Madsen","year":"2019","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.jad.2026.121662_bb0135","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1017\/S0033291706009299","article-title":"A new scale to assess the therapeutic relationship in community mental health care: STAR","volume":"37","author":"McGuire-Snieckus","year":"2007","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2026.121662_bb0140","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.121662_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.788155","article-title":"Therapeutic alliance and rapport modulate responses to psilocybin assisted therapy for depression","volume":"12","author":"Murphy","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jad.2026.121662_bb0150","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1176\/appi.ajp.20230661","article-title":"Misinterpretations and omissions: a critical response to Goodwin and colleagues\u2019 commentary on psilocybin-assisted therapy","volume":"181","author":"O\u2019Donnell","year":"2024","journal-title":"AJP"},{"key":"10.1016\/j.jad.2026.121662_bb0155","series-title":"How to Change Your Mind: The New Science of Psychedelics","author":"Pollan","year":"2018"},{"key":"10.1016\/j.jad.2026.121662_bb0160","series-title":"Behavioral Neurobiology of Psychedelic Drugs","first-page":"221","article-title":"Phenomenology, structure, and dynamic of psychedelic states","author":"Preller","year":"2018"},{"key":"10.1016\/j.jad.2026.121662_bb0165","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1177\/0269881119855974","article-title":"Emotional breakthrough and psychedelics: validation of the Emotional Breakthrough Inventory","volume":"33","author":"Roseman","year":"2019","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.121662_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012412","article-title":"Psychometric evaluation of the altered states of consciousness rating scale (OAV)","volume":"5","author":"Studerus","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2026.121662_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030800","article-title":"Prediction of psilocybin response in healthy volunteers","volume":"7","author":"Studerus","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2026.121662_bb0180","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1017\/S0033291723003653","article-title":"Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression","volume":"54","author":"Szigeti","year":"2024","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2026.121662_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2024.1465017","article-title":"Effects of therapeutic alliance on patients with major depressive disorder: a literature review","volume":"15","author":"Videtta","year":"2025","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jad.2026.121662_bb0190","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/wps.20238","article-title":"How important are the common factors in psychotherapy? An update","volume":"14","author":"Wampold","year":"2015","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jad.2026.121662_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2025.120637","article-title":"Pharmacodynamic biomarker \u2014 or psychotherapeutic process? Comment on \u201cThe role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.\u201d","volume":"394","author":"Wolff","year":"2026","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.121662_bb0200","doi-asserted-by":"crossref","DOI":"10.1177\/20503245251348272","article-title":"Reframing psychedelic regulation: tools, not treatments","volume":"11","author":"Wolff","year":"2025","journal-title":"Drug Sci. Policy Law"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726005136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726005136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:37:45Z","timestamp":1793597865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032726005136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":40,"alternative-id":["S0165032726005136"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2026.121662","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2026.121662","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"121662"}}